Benchmarking glycoform-resolved affinity separation - mass spectrometry assays for studying FcγRIIIa binding.

"Conflict of interest Authors MiH, MaH and TS are employed by the company Roche Diagnostics GmbH, Penzberg, Germany, are employees of Roche Diagnostics, the manufacturer of the column, Fc receptor and antibodies used in this research. The authors SL and FY are employed at Genentech, A Member of the Roche Group, South San Francisco, CA, United States. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision."

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by the LUMC Fellowship 2020 granted to ED-V and the project DisC with project number KICH1.ST01.20.014 of the research program KIC-ST which is (partly) financed by the Dutch Research Council (NWO). Additionally, we would like to thank Protein Metrics for providing us with the PMI-Byos software license for the evaluation of these results."